Nephrology – Page 4 – MedMeetings

Cognitive Performance in Patients with Chronic Kidney Disease: Results from the CKD-rein Cohort Study

This paper was presented on day 1 of the ERA Congress 2022 on May 19th 2022 by Drs. Marion Pepin, Julie Boucquemont, Monica Turinici from

Renal Glucocorticoid Receptor Expression and Clinical Course in Patients with IGA Nephropathy

This paper was presented on day 1 of the ERA th Congress 2022 on May 19 2022 by Drs. Bilge Tekin Ala, Saime Paydas, Bülent

The Importance of Addressing Multiple Risk Markers in Type 2 Diabetes: Results from the leader trial

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Emilie Hein from

Risk of Cardiovascular Disease, CKD, and Cardiovascular Mortality according to 2017 ACC/AHA Blood Pressure Categories in Diabetes

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Miryung Kim et

Renal, Cardiovascular(cv), and safety outcomes of Canagliflozin (CANA) according to baseline Albuminuria: A Credence Secondary Analysis

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr George Bakris MD

Comprehensive Ultrastructural Analysis strongly predicts Kidney Function Decline in the Multicenter Trident Cohort

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Matthew Palmer MD

Cardiovascular Disease and Medication use by CKD Risk groups in people with Type 2 Diabetes: A post HOC analysis from capture

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Guiseppina Russo MD

Association between the Urinary Proteome and Diabetic Retinopathy in the direct protect 1 and 2 trials

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Viktor Rotbain from

Effect of Reninangiotensin System Blockade Iin Immunoglobulin a Nephropathy only with Persistent Hematuria

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Hui Xu MD

During P2Y12 Antiplatelet Therapy, Treatment Of Anemia Was More Frequent Among PERIPHERAL Artery Disease Patients With Lower EGFR : The Euclid Trial

2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Judith Hsia et al from the CPC Clinical Research, Aurora,